Context: Psoriasis is one of the common chronic and recurrent infl ammatory skin disorders. The infl ammatory exudates in psoriasis are responsible for various lipid abnormalities as well as trigger a pro-oxidant and antioxidant imbalance resulting in copious generation of oxygen metabolites and proteases which may induce oxidative and proteolytic damage to plasma constituents and circulating red blood cells (RBCs) Aims: The aim was to evaluate dyslipidemia and erythrocyte oxidative stress as markers in plaque psoriasis. Materials and Methods: The study was performed on 120 male subjects, out of which 60 were patients of a moderate form of plaque psoriasis and 60 healthy age-matched controls. We evaluated lipid profi le, RBC morphological indices such as total RBC count, hematocrit, hemoglobin concentration, hematimetric indices, osmotic fragility, and reticulocyte count. We also evaluated antioxidant defenses catalase, superoxide dismutase, glutathione peroxidase (GPX), and oxidant malondialdehyde (MDA) levels. Statistical Analysis Used: Independent sample t-test was used to compare the means between two groups. Results: Psoriasis patients showed a signifi cant rise (P < 0.001) in total cholesterol, low-density lipoproteins (LDL), very LDL and triglycerides. The morphological indices of RBC presented with signifi cantly reduced (P < 0.05) RBC count, Hb concentration and Hematocrit, signifi cant increase (P < 0.05) in reticulocyte index and osmotic fragility. The antioxidant enzyme GPX activity was signifi cantly lower while the oxidant MDA levels were signifi cantly higher in patients with psoriasis (P < 0.001). Conclusions: Evaluation of the changes in RBC morphology, lipid profi le, and antioxidant enzymes may be considered as biomarkers in predicting the severity of plaque psoriasis.
INTRODUCTION
Psoriasis is a chronic and recurrent T cell-mediated disease involving CD 4 and CD8 lymphocytes. [1, 2] and a known oxidative stress condition. [3] These cells, upon encounter with an antigen become activated and migrate to the skin where they release a plethora of cytokines including tumoral necrosis factor-, Interferon-and interleukin-2, that initiate and perpetuate the infl ammatory response in the skin. [3] There are proliferation and accumulation of monocytes and macrophages in blood and tissues. [4] The monocytes and macrophages release oxygen metabolites and proteases which cause oxidative and proteolytic damage to plasma constituents and red blood cells (RBCs). [5] Psoriasis lesions that are clinically active, show infi ltration of leukocytes, and several studies report high levels of leukocyte activation products in the peripheral blood of these patients. [3, 4] Activated white blood cells (WBCs) are important sources of reactive oxygen species (ROS) and by diffusing across the cell membrane, ROS may trigger an oxidative stress within the cells. [5] ROS usually trigger an up-regulation of the antioxidant defenses, however, an oxidative stress will develop when an imbalance is developed between antioxidants and prooxidants. [6, 7] Human erythrocytes are important targets for the biological oxidative effects of free radicals as they are rich in polyunsaturated fatty acids, contain hemoglobin which is one of the most potent catalysts of lipid peroxidation.
tissues. [9] Presenting a limited biosynthesis capacity, the circulating erythrocyte suffers and accumulates physical and chemical changes, which become more pronounced with cell age, and whenever an unusual physical or chemical stress develops. [8, 9] Many modifi cations are known to occur throughout the life span of the circulating RBCs, such as change in cell size, volume and in enzymatic activity. [8] [9] [10] The invasion of the erythrocyte membrane by peroxidants, which occurs in infl ammatory conditions like psoriasis, alters the cellular metabolic function and antioxidant defenses such as catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPX). [11, 12] These components build up an effi cient defense system inside the erythrocyte. SOD converts superoxide radicals into hydrogen peroxide, which generates the most reactive species, hydroxyl anion radical under the appropriate conditions. Hydrogen peroxide is degraded to water and oxygen via GPX at physiological concentrations. [12, 13] When hydrogen peroxide concentration increases until toxic levels, CAT also contributes to the metabolism of this substrate. In this way, they play an important role in the protective mechanisms against exposure to oxidative stress. By diffusing across the RBC membrane, oxygen metabolites trigger an oxidative stress within the cells which if assessed may prove to be an important biomarker of diagnosis and prognosis of the disease.
The present study focuses on the assessment of erythrocyte oxidative stress in patients with chronic plaque psoriasis by evaluating lipid peroxidation, RBC morphological changes and antioxidant defenses.
MATERIALS AND METHODS
The study comprised of total 120 male subjects aged 20-50 years, out of which 60 were patients diagnosed with moderate to severe form of plaque psoriasis in the outpatient Department of Dermatology, Kamineni Institute of Medical Sciences, Narketpally over a time period of 12.10.12-18.6.14. Patients were evaluated clinically by the dermatologist based on history, Cutaneous and systemic examination including location, severity of erythema, amount of scaling, and thickness of psoriatic plaques. 60 age-matched healthy controls were enrolled for this study, recruited from healthy volunteers and patients attending skin outpatient department for cosmetic problems like acne and pigment disturbances. The study was approved by Institutional Ethics Committee. Informed consents were taken from the patients as well as the controls, before collection of the blood sample.
Inclusion criteria
All the patients included were having a psoriasis area and severity index (PASI) score of 8-12 (PASI score 8-12 for moderate psoriasis). [14] Exclusion criteria 1 . The controls, as well as the patients, receiving any kind of medication, namely antioxidants, vitamins or methotrexate.
2. Patients with diabetes mellitus, renal diseases, hepatic diseases, and any other neuro-degenerative disorders. 3. Patients who had received any systemic or local steroid medication or any phototherapy treatment for at least 1 month prior to blood collection.
Clinical parameters were documented in a well-designed proforma prior to collection of 10 ml of fasting venous blood from each of these patients, for carrying out hematological and biochemical investigations in central biochemistry laboratory of KIMS hospital.
Erythrocyte morphology study
Whole blood (ethylenediaminetetraacetic acid as anticoagulant) was used for determining RBC count; Hb concentration, RBC indices that is, mean corpuscular volume (MCV), mean corpuscular hemoglobin concentration (MCH), MCH concentration (MCHC), and reticulocyte index by an automated cell counter (Autocounter AC 970).
Red blood cells osmotic fragility
The osmotic fragility was measured by saline solutions buffered to pH 7.4, used at different concentrations (1.0-9.0 g/l). Heparinized blood was added to these test tubes in the proportion of 1:100; Hemolysis was evaluated after 30 min of incubation at room temperature, by measuring the absorbance at 540 nm of the supernatant obtained after centrifugation (1500 g for 5 min).
Erythrocyte antioxidant defenses
Heparinized blood was centrifuged at 1000 g for 10 minute at 4°C, the buffy coat was discarded, and the isolated RBC pellet was hemolyzed in 4 times its volume of ice-cold high-performance liquid chromatography-grade water and again centrifuged at 4°C. The erythrocyte lysate was then used to evaluate the CAT, SOD, and GPX activity.
Glutathione peroxidase activity assay
Glutathione peroxidase activity was determined with Cayman kits (Item no. 703102, Ann Arbor, MI 48108, USA) at 25°C by colorimetry at 340 nm, based on the method of Paglia and Valentine, [15] which requires cumene hydroperoxide as a substrate. Before analysis, the erythrocyte lysates were diluted to 20-fold with sample buffer. The fi nal concentration of reagents in the assay was those recommended by the manufacturer. The GPX activity was measured in IU/g of Hb.
Superoxide dismutase activity assay
Superoxide dismutase activity was determined with Cayman kits (item no. 706002, Ann Arbor, MI 48108, USA) at 25°C by colorimetry at 340 nm, based on the method of Marklund. [16] This method employs xanthine and xanthine oxidase to generate superoxide radicals which react with 2-(-4-iodophenyl)-3-(4-nitrophenol)-5-phenyl tetrazolium chloride to form red formazone dye. The SOD activity is then measured by the degree of inhibition of this reaction. SOD units were obtained from the standard curve expressed in IU/g of Hb.
Catalase assay
Catalase activity was assayed based on the method of Johansson and Borg, [17] using the Cayman kits (item no. 707002, Ann Arbor, MI 48108, USA). The method is based on the reaction of the enzyme with methanol in the presence of an optimal concentration of H 2 O 2 . The formaldehyde produced is measured calorimetrically with purpald as the chromogen at 340 nm. CAT activity is calculated as the amount of enzyme that will cause the formation of 1.0 nmol of formaldehyde per minute expressed in nmol/min/ml.
TBAR assay
Plasma malondialdehyde (MDA) levels were determined by the method of Richard et al. [18] using the Cayman kits (item no. 10009055, Ann Arbor, MI 48108, USA). In this method after centrifuging the blood at 1000 g for 10 min at 4°C, the top yellow plasma layer is pipetted off. The MDA-TBA adduct formed by the reaction of MDA and TBA under high temperature (90-100°C) and acidic condition is measured colorimetrically at 530-540 nm.
Lipid profi le
Serum total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL) were done by autoanalyzer (Hitachi 912). Very LDL (VLDL) was calculated by Friedewald's equation. [19] 
Body mass index
The body mass index of all the subjects was calculated by the accepted formula weight (kg)/(height [meter] 2 ).
Statistical analysis
The data were expressed as mean ± standard deviation. Comparison of data was done by independent sample t-test and P values were calculated using the Open EPI6 software (Open Epi Version 2.3.1 from Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA). P < 0.05 was considered to be signifi cant.
RESULTS
All the 120 subjects were investigated for parameters of RBC morphological indices as well as antioxidant enzymes. The baseline data and lipid profi le are described in Table 1 . RBC indices are given in Table 2 . The antioxidant defenses and MDA levels are compared. We observed signifi cantly lower (P < 0.05) RBC count, Hb concentration and higher reticulocyte index, erythrocyte osmotic fragility in the psoriasis group (P < 0.05). There was no signifi cant difference observed in MCV and MCH, whereas MCHC of the psoriasis group was lower in comparison to control. The erythrocyte GPX activity was found to be signifi cantly low (P < 0.05) and the plasma MDA levels were signifi cantly higher in psoriasis patients in comparison to the controls (P < 0.001). There was no signifi cant difference observed in CAT and SOD activity among both the groups.
DISCUSSION
Plaque psoriasis is one of the most common forms of psoriasis. This inflammatory skin disease often encountered clinically seems to impose an oxidative stress condition. [2] Previous studies have reported dyslipidemia to be signifi cantly associated with psoriasis. [20, 21] In the current study, we observed signifi cantly high levels of TC, LDL, VLDL, and TG in psoriasis patients than controls. However, we did not observe any change in the levels of HDL. Our study is concurrent with that of Lateef et al., who has reported similar fi ndings in their study on lipid profi le and protein fractions in psoriasis. [22] The association of dyslipidemia may be due to chronic infl ammation, which is a characteristic feature of psoriasis, plays a role in the initiation and progression 138.29±34.76 0.000** **P < 0.001. BMI = Body mass index, HDL = High-density lipoprotein, LDL = Lowdensity lipoproteins, VLDL = Very low-density lipoproteins, TC = Total cholesterol of dyslipidemia and atherosclerosis. [20] [21] [22] In the present study, We found that psoriasis patients presented signifi cantly higher number of WBCs [ Figure 1 ]. The leukocytosis is mainly due to an increased number of neutrophils.
It has been observed that psoriasis is characterized by high levels of circulating neutrophil activation products, that is, elastase and lactoferrin. [5] The higher plasma levels of elastase and lactoferrin may be responsible for further neutrophil activation. [4, 5] It is known that neutrophil activation is also linked to the production of oxygen metabolites, which may induce oxidative and proteolytic modifications to plasma constituents and neighboring cells such as circulating erythrocytes. [12] The oxidative stress is bestmanifested on erythrocyte, as the RBC membrane is rich in lipids, does not have a nucleus, all the metabolic enzymes are present in its cytoplasm. [10] Hence, the enzyme activity can be studied and correlated with the extent of damage done by an infl ammatory reaction. Some oxygen metabolites are highly reactive, whereas others, like hydrogen peroxide, are less reactive and have the ability to diffuse easily across the erythrocyte membranes. [3] We observed a signifi cant increase in the osmotic fragility and reticulocyte index in moderate form of plaque psoriasis (P < 0.05) [ Table 1 ]. The ROS may, therefore, impose oxidative modifi cations upon the membrane and within the RBC, leading to structural modifi cations which may cause premature senescence and hemolysis. [23, 24] This may be the reason for a signifi cant rise in osmotic fragility, reticulocyte index, fall in MCHC and hematocrit (P < 0.05) observed in our study. Except MCHC, other RBC indices like MCV, MCH were not altered signifi cantly in the present study. Our results are similar to the fi ndings of Rocha-Periera et al. who found that the blood indices were markedly altered in severe form of psoriasis but not in mild or moderate forms. [1, 2] The evaluation of plasma levels of lipid peroxidation [ Table 2 ] showed a signifi cantly higher value of MDA levels in psoriasis (P < 0.001) indicating higher lipid peroxidation. The ROS causes peroxidation of RBC membrane, the peroxidants attach to the RBC membrane and trigger alteration of the cellular antioxidant enzyme activity. [24] Gaining the inside of the RBC, they will trigger the erythrocyte antioxidant defense mechanisms. [25] In psoriasis patients, we observed a signifi cant reduction in the erythrocyte antioxidant enzymatic activity GPX (P < 0.05). This enzyme is particularly involved in the detoxifi cation of the cell in oxygen radicals. Our study is concurrent with that of Santosh-Silvia et al. who also had reported similar fi ndings.
[18] Surprisingly, we did not observe any signifi cant difference in the CAT as well as SOD activity in psoriasis patients. Our study does not agree with Therond et al. and Rocha-Pereira et al. who has reported signifi cantly lower activities of CAT in psoriasis patients. [26, 1] In the case of SOD, some authors reported a reduced activity in psoriasis patients while others, including ourselves, found no signifi cant change. [26, 27] This may be due to other associated factors like dietary patterns, lifestyle, exercise etc., which may interfere with the antioxidant status of the body. [27] Furthermore, the difference may be due to the fact that patients included in previous studies, suffer from different forms of psoriasis such as localized plaque psoriasis, pustular psoriasis or erythroderma and they may be undergoing various forms of treatments, but our patients had no erythroderma or generalized pustulosis. Our fi ndings are in concurrent with that of Rocha-Pereira et al. who reported decrease in GPX activity in mild and moderate form of psoriasis, followed by marked decrease in activity of all the three enzymes, as the disease progresses from mild to severe form with enlargement of the psoriatic lesion. [1, 4] In summary, we found erythrocyte morphological changes denoting enhanced damage, namely a rise in osmotic fragility, reticulocyte index, oxidant and antioxidant enzyme activity can be associated with progress of the disease. Reductions in total RBC count, rise of reticulocyte index, plasma MDA levels with failure of membrane antioxidant defenses, and a rise in the osmotic fragility, are all markers of RBC senescence or damage, and these changes were observed in psoriasis. Since the present study focuses on the erythrocyte as a marker for the progress of the disease, we suggest that a regular evaluation of these RBC markers in patients with moderate plaque psoriasis could be of value in predicting in advance the worsening of the disease and therefore enabling earliest and better intervention with antioxidants as adjunctive therapy.
However, further research should be carried out on other infl ammatory and stress markers like C-reactive protein, ferritin, and ceruloplasmin to augment the present study. 
